As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide, aimed at transforming the treatment of type 2 diabetes (T2D), and related cardiovascular (CV) and renal comorbidities, the CMCA considers Rochester Regional Health a key member of the alliance.
“Cardiometabolic disease is one of the leading population health threats impacting our communities and patients, regardless of where they may live,” said Mikhail Kosiborod MD, Cardiometabolic Center Alliance Executive Director. “The Cardiometabolic Center Alliance is proud to partner with Rochester Regional Health as the newest member of the CMCA as their commitment to providing the highest quality cardiometabolic care to the communities they serve complements the overarching mission of the CMCA.”
Rochester Regional Health is a an integrated health services organization serving the people of Western New York, the Finger Lakes, St. Lawrence County, and beyond. The system includes nine hospitals; primary and specialty practices, rehabilitation centers, ambulatory campuses and immediate care facilities; innovative senior services, facilities and independent housing; a wide range of behavioral health services; and Rochester Regional Health Laboratories and ACM Global Laboratories, a global leader in patient and clinical trials.
“We are absolutely thrilled to be Charter Members of the Cardiometabolic Center Alliance. Dr. Kosiborod and his team are world-renowned leaders for their management of complex patients with cardiac disease and underlying co-morbidities such as diabetes, obesity and kidney disease,” said Scott Feitell MD, Director of Heart Failure, charter member of Cardiometabolic Center Alliance. “Rochester Regional Health is excited to have the opportunity to partner with a nationally recognized team and provide cutting edge and state-of-the-art care right here in Rochester, NY! Our mission, which very much overlaps with the CMCA, is to provide a comprehensive medical home for these patients, using a multi-disciplinary team model including cardiologists, endocrinologists, bariatric specialists, dieticians, and many others to ensure patients are afforded every opportunity to live a full and meaningful life, despite the burden of diabetes and heart disease. As a charter member of this alliance, we will also gain access to cutting edge clinical trials that may further improve outcomes for these patients! This is a huge win for patients in upstate New York!”
The Cardiometabolic Center Alliance is a national collaborative of healthcare organizations committed to helping patients better manage their conditions for a better quality of life and helping to ease the burden on health care organizations. Across its aligned member sites, care will be delivered via a standardized, patient-centered, team-based, comprehensive risk reduction approach based on a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, MO. The overarching goals of the CMCA and its members include: improving the quality of care and outcomes for patients with cardiometabolic disease, creating platforms for real world evidence generation and clinical trials, as well as producing tangible benefits to healthcare organizations in a value-based model of care delivery.